In the world economic growth, the Asparaginase Industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Asparaginase market size to maintain the average annual growth rate of XXX from XXX million $ in 2014 to XXX million $ in 2019, SMI analysts believe that in the next few years, Asparaginase market size will be further expanded, we expect that by 2024, The market size of the Asparaginase will reach XXX million $.
Asparaginase is an enzyme used as a catalyzing agent in the hydrolysis of l-asparagine to l-aspartic acid and ammonia. It is also used in the treatment of childhood acute lymphoblastic leukemia and acute lymphocytic leukemia. In the food industry, asparaginase is used as a processing aid in the manufacturing of snacks and biscuits.
High incidence of childhood acute lymphoblastic leukemia is expected to propel the growth of the global asparaginase market over the forecast period. For instance, according to Leukemia and Lymphoma Society’s 2018-2019 facts, the incidence of acute lymphoblastic leukemia was 7.8 (per 100,000) in children aged 1-4 years during 2011-2015. Moreover, increasing the prevalence of acute lymphocytic leukemia is also expected to aid in the growth of the market. For instance, according to the National Cancer Institute, the U.S. is expected to record 6,150 new cases of acute lymphocytic leukemia in 2020.
Launch of new retail food products is expected to offer lucrative growth opportunities for players in the global asparaginase market. For instance, in April 2020, Lotus Bakeries launched new vegan cream-filled sandwich biscuits in the U.K. Moreover, R&D in asparaginase is also expected to aid in the growth of the market. For instance, in January 2019, researchers from The University of Texas MD Anderson Cancer Center reported a new LC-MS/MS bioanalytical method that incorporates rapid quenching of asparaginase for measurement of asparagine, aspartic acid, glutamine, and glutamic acid, in mouse models of cancer.
In the Asia Pacific, significant growth in the food industry is expected to boost demand for asparaginase, thereby aiding in the growth of the global asparaginase market. For instance, according to India Brand Equity Foundation, the retail food sector in India is expected to increase from around US$ 70 billion in 2008 to US$ 150 billion by 2025.
However, the use of asparaginase in the treatment of childhood acute lymphoblastic leukemia is also associated with allergic reactions such as anaphylaxis and bronchospasm. This, in turn, is expected to hinder the growth of the global asparaginase market.
Key Takeaways:
- High incidence of childhood acute lymphoblastic leukemia to augment the growth of the global asparaginase market over the forecast period
- Some players in the market have witnessed strain in the supply of asparaginase. For instance, in March 2020, Jazz Pharmaceuticals plc announced that the company is witnessing disruptions (unrelated to COVID-19) in the supply of Erwinaze (asparaginase Erwinia chrysanthemi).
- Major players in the market are focused on adopting collaboration and partnership strategies to expand their product portfolio. For instance, in February 2020, ERYTECH Pharma, a clinical-stage biopharmaceutical company, partnered with German Red Cross Blood Donor Service Baden-Württemberg-Hessen (GRCBDS) for the supply of donor red blood cells to manufacture its product candidates, including eryaspase that consists of L-asparaginase encapsulated inside donor-derived red blood cells, in Europe.
- Major players operating in the global asparaginase market include, Shire Plc, Medac GmbH, Kyowa Hakko Kirin Co., Ltd., Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd., Taj Pharmaceuticals, ERYTECH Pharma, Jazz Pharmaceuticals plc, Sichuan Mingxing Pharmaceutical Co Ltd., and United Biotech (P) Limited
This Report covers the manufacturers' data, including: shipment, price, revenue, gross profit, interview record, business distribution, etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment, etc. cover different segment market sizes, both volume, and value. It also covers different industries' clients information, which is very important for manufacturers. If you need more information, please contact SMI
Section 1: Definition
Section (2 3): Manufacturer Detail
╼ Jazz Pharmaceuticals
╼ Shire
╼ Medac GmbH
╼ Kyowa Hakko Kirin
╼ Qianhong Bio-pharma
╼ Taj Pharmaceuticals
╼ Mingxing Pharma
╼ SL Pharma
╼ United Biotech
Section 4: Region Segmentation
╼ North America Country (United States, Canada)
╼ South America
╼ Asia Country (China, Japan, India, Korea)
╼ Europe Country (Germany, UK, France, Italy)
╼ Other Country (Middle East, Africa, GCC)
Section (5 6 7): Segmentation
Product Type Segmentation -
╼ Escherichia Coli
╼ Erwinia Chrysanthemi
╼ Pegylated
Industry Segmentation -
╼ Acute Lymphoblastic Leukemia
╼ Acute Myeloid Leukemia
Channel (Direct Sales, Distributor) Segmentation
Section 8: Trend (2019-2024)
Section 9: Product Type Detail
Section 10: Downstream Consumer
Section 11: Cost Structure
Section 12: Conclusion
Request Discount 
Inquire Before Buy
